This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Chiesi Farmaceutici S.p.A.
Drug Names(s): CHF-4226, TA-2005
Description: Carmoterol is a long-acting, selective 2-adrenergic receptor agonist, provided in a pressurized metered dose inhaler (pMDI) using an HFA propellant.
Deal Structure: Carmoterol is being developed by Chiesi Farmaceutici through a partnership with Tanabe.
In October 2007, Mitsubishi Tanabe Pharma Corporation was formed by the merger of Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation.
Partners: Mitsubishi Tanabe Pharma Corporation
Additional information available to subscribers only: